Related Experiment Video
Updated: Nov 28, 2025

In Vitro Differentiation of Human Mesenchymal Stem Cells into Functional Cardiomyocyte-like Cells
Published on: August 9, 2017
Enhancing Matured Stem-Cardiac Cell Generation and Transplantation: A Novel Strategy for Heart Failure Therapy
Ampadu O Jackson1,2,3, Ganiyu A Rahman3, Kai Yin4
1Department of Biochemistry and Molecular Biology, University of South China, Hengyang, 421001, Hunan Province, China.
Insights
Strategies to mature stem-derived cardiac cells (S-CCs) are crucial for treating heart failure (HF). Recent multi-omic analyses reveal methods to improve S-CC maturation for enhanced patient recovery in regenerative medicine.
Area of Science:
- Regenerative Medicine
- Cardiovascular Research
- Stem Cell Biology
Background:
- Heart failure (HF) is a leading cause of death globally.
- Stem cells (SCs) show potential for treating myocardial infarction (MI), but immature phenotypes limit clinical use.
- Maturation of stem-derived cardiac cells (S-CCs) is essential for effective HF therapy.
Purpose of the Study:
- To summarize recent strategies for generating mature S-CCs.
- To discuss cardiac patch formation and transplantation for HF recuperation.
- To advance the understanding of S-CC generation for regenerative medicine.
Main Methods:
- Unbiased multi-omic analysis (genomics, transcriptomics, epigenomics, proteomics, metabolomics).
- Review of recently discovered S-CC maturation strategies.
- Discussion of clinical trial data on cardiac patches for HF.
Main Results:
- Multi-omic analysis identified key strategies for S-CC maturation.
- Specific undisclosed strategies enhance S-CC maturity.
- Cardiac patches accelerated HF recovery in clinical trials.
Conclusions:
- Efficient generation of mature S-CCs is vital for regenerative medicine.
- Improved S-CC maturation holds promise for enhanced HF patient recovery.
- Further understanding of these strategies can optimize cell-based therapies for heart disease.
Abstract:
Heart failure (HF) remains one of the major causes of morbidity and mortality worldwide. Recent studies have shown that stem cells (SCs) including bone marrow mesenchymal stem (BMSC), embryonic bodies (EB), embryonic stem (ESC), human induced pluripotent stem (hiPSC)-derived cardiac cells generation, and transplantation treated myocardial infarction (MI) in vivo and in human. However, the immature phenotypes compromise their clinical application requiring immediate intervention to improve stem-derived cardiac cell (S-CCs) maturation. Recently, an unbiased multi-omic analysis involving genomics, transcriptomics, epigenomics, proteomics, and metabolomics identified specific strategies for the generation of matured S-CCs that may enhance patients' recovery processes upon transplantation. However, these strategies still remain undisclosed. Here, we summarize the recently discovered strategies for the matured S-CC generation. In addition, cardiac patch formation and transplantation that accelerated HF recuperation in clinical trials are discussed. A better understanding of this work may lead to efficient generation of matured S-CCs for regenerative medicine. Graphical abstract.
Related Concept Videos
Stem Cell Therapy for Tissue Regeneration
Types of Stem Cells used in Stem Cell Therapy
The two main cell...
Stem Cell Culture

